Skip to main content

Table 1 Antimalarial treatment outcomes for the 4ABC Trial [19]

From: Dealing with indeterminate outcomes in antimalarial drug efficacy trials: a comparison between complete case analysis, multiple imputation and inverse probability weighting

Treatment Cured Missing outcome (indeterminate recurrence) Recrudescence New Infection Total
AL 847 (73.0%) † 29 (2.5%) 41 (3.5%) 243 (21.0%) 1,160
ASAQ 744 (81.8%) 20 (2.2%) 18 (2.0%) 127 (14.0%) 909
DP 1,242 (91.2%) 13 (1.0%) 22 (1.6%) 85 (6.2%) 1,362
  1. AL artemether-lumefantrine , ASAQ artesunate-amodiaquine , DP dihydroartemisinin-piperaquine
  2. †Percentages are out of total patients treated with that regimen